DrugPatentWatch Database Preview
Email this page to a colleague» See Plans and Pricing
« Back to Dashboard
Gentak is a drug marketed by Akorn and is included in one NDA.
The generic ingredient in GENTAK is gentamicin sulfate. There are fifteen drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the gentamicin sulfate profile page.
A generic version of GENTAK was approved as gentamicin sulfate by SANDOZ INC on December 31st, 1969.
Pharmacology for GENTAK
|Drug Class||Aminoglycoside Antibacterial |
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Akorn||GENTAK||gentamicin sulfate||SOLUTION/DROPS;OPHTHALMIC||064163-001||Oct 12, 2001||AT||RX||No||No||Start Trial||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|